These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22418887)

  • 1. Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications.
    Northup PG; Argo CK; Shah N; Caldwell SH
    Semin Liver Dis; 2012 Feb; 32(1):39-48. PubMed ID: 22418887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
    Targher G; Chonchol M; Miele L; Zoppini G; Pichiri I; Muggeo M
    Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasmapheresis in combine therapy of hypercoagulation syndrome in hematogenic thrombophilia].
    Vasil'ev SA; Gorodetskiĭ VM; Kalinin NN; Berkovskiĭ AL; Petrova VI; Rudakova VE; Orel EB; Sergeeva EV; Kravchenko SK; Margolin OV; Efremov EE; Shevelev AA; Tsvetaeva NV; Avdonin PV; Vorob'ev AI
    Ter Arkh; 2002; 74(7):61-4. PubMed ID: 12181839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime.
    Blonsky JJ; Harrison SA
    Aliment Pharmacol Ther; 2008 May; 27(10):855-65. PubMed ID: 18315584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
    Schwimmer JB
    Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy loss and thrombophilia: the elusive link.
    Bennett SA; Bagot CN; Arya R
    Br J Haematol; 2012 Jun; 157(5):529-42. PubMed ID: 22449204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
    Salt WB
    J Insur Med; 2004; 36(1):27-41. PubMed ID: 15104027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
    Sutherland DE; Weitz IC; Liebman HA
    Am J Hematol; 2003 Jan; 72(1):43-52. PubMed ID: 12508268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease in individuals with severe obesity.
    Haynes P; Liangpunsakul S; Chalasani N
    Clin Liver Dis; 2004 Aug; 8(3):535-47, viii. PubMed ID: 15331062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic symptoms in non-alcoholic fatty liver disease.
    Newton JL
    Dig Dis; 2010; 28(1):214-9. PubMed ID: 20460914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy.
    Kopec KL; Burns D
    Nutr Clin Pract; 2011 Oct; 26(5):565-76. PubMed ID: 21947639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two tales of coagulation in liver transplantation.
    Warnaar N; Lisman T; Porte RJ
    Curr Opin Organ Transplant; 2008 Jun; 13(3):298-303. PubMed ID: 18685321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.
    Adams LA; Lindor KD; Angulo P
    Am J Gastroenterol; 2004 Jul; 99(7):1316-20. PubMed ID: 15233671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.